Trump Administration Overhauls Title X Grants to Focus on Fertility Over Contraceptive Access

New federal Title X rules pivot toward fertility and restorative medicine as the Trump administration seeks to reverse the falling US birth rate.

By: AXL Media

Published: Apr 18, 2026, 4:14 AM EDT

Source: Information for this report was sourced from KFF Health News

Federal Strategy Shifts Toward Pronatalist Policy Goals

The Trump administration has officially redirected the nation’s primary family planning safety net to align with broader goals of reversing the declining American birth rate. According to recent data from the Centers for Disease Control and Prevention, U.S. births fell to 3.6 million in 2025, continuing a long-term downward trend that has seen the fertility rate drop by 23% since 2007. In response, President Donald Trump has called for policies that incentivize larger families, including potential baby bonuses and expanded fertility planning. This strategic pivot marks a departure from five decades of bipartisan focus on preventing unintended pregnancies among low-income populations.

Title X Funding Notice Omits Conventional Contraceptive Language

In a move described by critics as a wholesale redefinition of reproductive care, the Department of Health and Human Services (HHS) released a fiscal year 2027 grant notification that almost entirely omits the word contraception. The document, which invites nonprofits to apply for Title X grants starting in October 2026, refers to hormonal birth control as "overprescribed" and associated with "negative side effects." Instead of prioritizing the prevention of unintended pregnancy, the new guidelines focus on "body literacy" and the treatment of underlying health conditions. Jessica Marcella, a former senior official in the Biden administration, stated that the notice represents an attempt to use the family planning program as a "Trojan horse" for an entirely different ideological agenda.

Restorative Reproductive Medicine Replaces Public Health Interventions

The new grant criteria prioritize what advocates call restorative reproductive medicine, an approach that emphasizes lifestyle interventions and the diagnosis of chronic conditions over pharmaceutical or surgical treatments. The funding notice specifically lists polycystic ovary syndrome (PCOS), endometriosis, and uterine fibroids in women, along with low testosterone and erectile dysfunction in men, as primary areas of focus. According to Emma Waters, a senior policy analyst at the Heritage Foundation, this change empowers women to understand their fertility cycles rather than simply relying on symptom-focused hormonal suppression. However, public health experts warn that this shift ignores the prim...